Le Lézard
Classified in: Science and technology
Subjects: Photo/Multimedia, Personnel, Award

Vicky Thomas of Vivint Smart Home Named a Utah Business 20 In Their 20s Honoree


Vivint Smart Home today announced that Vicky Thomas, director of product management and vertical lead for apps, is a 2019 Utah Business 20 In Their 20s honoree. Utah Business selected Thomas for her role in inspiring the innovation at the heart of one of the leading smart home companies in North America.

"In addition to her tremendous intellectual curiosity and technical prowess, Vicky is incredibly passionate about building great people, teams and cultures," said Jeremy Warren, chief technology officer at Vivint Smart Home. "This unique combination of a fantastic product manager and outstanding leader has led to the development of some of our most innovative products."

Thomas led product management to help Vivint create truly smart homes using artificial intelligence, one of Vivint's most ambitious initiatives to date. In her current role, she oversees Vivint mobile apps, which are a critical component to a complete smart home experience. As the primary way to manage a Vivint smart home, the mobile apps are the interface more than 1.5 million customers use to control their home from anywhere.

As a dedicated leader, Thomas has grown her team at Vivint from 13 employees to more than 40 in the past year. She also runs the Career Growth Track for the Vivint Women employee resource group. In addition to her job responsibilities, she is active in the community through volunteering, championing STEM education and speaking at conferences.

Before Vivint, Thomas was a product manager at Adobe and an early employee at Utah-based Lucid Software. She has a bachelor's degree in aerospace engineering from the Massachusetts Institute of Technology.

The annual Utah Business 20 In Their 20s program honors Utah's young and ambitious professionals who are already taking the business world by storm and who are sure to continue impacting Utah's business community for decades to come. Utah Business recognized Thomas and the other 2019 honorees at an awards ceremony in Salt Lake City, on the Utah Business website and in the magazine's November print issue.

About Vivint Smart Home

Vivint Smart Home is a leading smart home company in North America. Vivint delivers an integrated smart home system with in-home consultation, professional installation and support delivered by its Smart Home Pros, as well as 24/7 customer care and monitoring. Dedicated to redefining the home experience with intelligent products and services, Vivint serves more than 1.5 million customers throughout the U.S. and Canada. For more information, visit www.vivint.com.


These press releases may also interest you

at 08:05
Axcella Health Inc. , a biotechnology company pioneering the research and development of novel multifactorial interventions to address dysregulated metabolism and support health, today announced mechanistic data for AXA4010 that are being presented...

at 08:00
Genius Central, founded in October 1999, is celebrating 20 years in business providing essential components of the supply chain to the natural and specialty grocery industry. Processing over $2 billion in orders annually, the company's mission to...

at 08:00
Cellular Biomedicine Group Inc. ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies, announced early data from its ongoing investigator initiated trial ("IIT") at...

at 07:55
AstraZeneca today presented results from the interim analysis of the Phase III ELEVATE TN trial, showing that CALQUENCE® (acalabrutinib) combined with obinutuzumab or as monotherapy significantly improved progression-free survival (PFS) compared to...

at 07:33
AbbVie , a research-based global biopharmaceutical company, today announced results from an extended follow-up analysis of the Phase 3 E1912 clinical study ? designed and conducted by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and sponsored by...

at 07:30
AbbVie , a research-based global biopharmaceutical company, today announced new data from the Phase 2 CAPTIVATE (PCYC-1142) clinical trial,1 evaluating IMBRUVICA® (ibrutinib) in combination with VENCLEXTA®/VENCLYXTO® (venetoclax) in previously...



News published on 13 november 2019 at 15:35 and distributed by: